Vibegron is a selective beta-3 adrenergic agonist indicated for the treatment of symptoms associated with overactive bladder, such as urgency, frequency, and urge urinary incontinence. This category provides… Read more


![Chemical structure of (1R,2R,5S,6S)-3-Azatricyclo[4.2.1.02,5]non-7-en-4-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F677757-32-3-1R2R5S6S-3-Azatricyclo4.2.1.025non-7-en-4-one.png&w=3840&q=75)

![Chemical structure of (6S)-4-Hydroperoxy-N-(4-(((2R,5R)-5-((R)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6S-4-Hydroperoxy-N-4-2R5R-5-R-hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (6S)-N-(4-(Hydroxy((2S,5R)-5-((R)-hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F6S-N-4-Hydroxy2S5R-5-R-hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)






![Chemical structure of (R)-4-Oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-4-Oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxylic-Acid.png&w=3840&q=75)

![Chemical structure of (R)-N-(4-(((2R,5S)-5-((S)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-N-4-2R5S-5-S-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (R)-N-(4-(((2S,5R)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-N-4-2S5R-5-R-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (R)-N-(4-(((2S,5S)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-N-4-2S5S-5-R-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2R,5R)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2R5R-5-R-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2R,5R)-5-((S)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2R5R-5-S-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2R,5S)-5-((R)-Hydroxy(phenyl)methyl)-1-nitrosopyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2R5S-5-R-Hydroxyphenylmethyl-1-nitrosopyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2R,5S)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2R5S-5-R-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2S,5R)-5-((R)-Hydroxy(phenyl)methyl)-1-nitrosopyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2S5R-5-R-Hydroxyphenylmethyl-1-nitrosopyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2S,5R)-5-((S)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2S5R-5-S-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2S,5S)-5-((R)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2S5S-5-R-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)
![Chemical structure of (S)-N-(4-(((2S,5S)-5-((S)-Hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FS-N-4-2S5S-5-S-Hydroxyphenylmethylpyrrolidin-2-ylmethylphenyl-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxamide.png&w=3840&q=75)

![Chemical structure of 3-Azatricyclo[4.2.1.02,5]non-7-en-4-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F14735-70-7-3-Azatricyclo4.2.1.025non-7-en-4-one.png&w=3840&q=75)


![Chemical structure of Methyl (S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1190392-23-4-Methyl-S-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxylate.png&w=3840&q=75)

![Chemical structure of Sodium (S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1421271-01-3-Sodium-S-4-oxo-4678-tetrahydropyrrolo12-apyrimidine-6-carboxylate.png&w=3840&q=75)





Vibegron is a selective beta-3 adrenergic agonist indicated for the treatment of symptoms associated with overactive bladder, such as urgency, frequency, and urge urinary incontinence. This category provides essential analytical tools, including reference standards of the parent drug, its synthetic impurities, metabolites, and stable isotope labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for critical tasks such as impurity profiling, method validation, and routine quality control. Stable isotope labelled internal standards are particularly valuable for ensuring the accuracy of mass spectrometry-based assays, while a comprehensive selection of degradation products, intermediates, and metabolic derivatives allows researchers to monitor the safety and integrity of the drug throughout the development process. By utilizing these precise reference materials, analytical chemists can maintain strict compliance with regulatory standards and ensure the efficacy and purity of pharmacological products during formulation and manufacturing.